Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/03/24 08:00:03 on US and Canada Markets.
2024-04-03 08:00:03 ET Scott Buck from H.C. Wainwright issued a price target of $2.50 for FPAY on 2024-04-03 06:07:00. The adjusted price target was set to $2.50. At the time of the announcement, FPAY was trading at $1.155. The overall price target consensus is at $4.00 ...
2024-04-03 08:00:03 ET Chris Caso from Wolfe Research issued a price target of $31.00 for INTC on 2024-04-03 06:04:00. The adjusted price target was set to $31.00. At the time of the announcement, INTC was trading at $43.94. The overall price target consensus is at $40.7...
2024-04-03 08:00:03 ET Ruben Roy from Stifel Nicolaus issued a price target of $45.00 for INTC on 2024-04-03 06:08:00. The adjusted price target was set to $45.00. At the time of the announcement, INTC was trading at $43.94. The overall price target consensus is at $40.7...
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences and diagnostics, announced today its participation in the American Association for Cancer Research Annual Meeting (AACR) . At the meeting, which will take place from April 5 to 10, 2024, in San Diego, CA, Agilent will hig...
SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal fourth quarter 2024 financial results on Thursday, April 25, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ...
Office Properties Income Trust (Nasdaq: OPI) today announced that it will issue a press release containing its first quarter 2024 financial results after the Nasdaq closes on Wednesday, May 1, 2024. On Thursday, May 2, 2024 at 10:00 a.m. Eastern Time, President and Chief Operating Officer Yae...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that on April 1, 2024, the Compensation Committee of Equillium’s Board of Directors granted an inducement awa...
SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a peer-reviewed study that compared optical genome mapping (OGM) to classical cytogenetic techniques used for analysis of solid tumor cancer samples consisting of soft tiss...
LAKE FOREST, Ill., April 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced effectiveness o...
SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Redhook Brewery , makers of pure Pacific Northwest ale, and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is introducing the brewery’s newest offering: Big Juicy Ballard IPA , a higher ABV, high-octane juice bomb b...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
2.13%Change Percent:
Astellas Pharma Inc. ADR Company Name:
ALPMY Stock Symbol:
OTCMKTS Market: